Immunotherapy for metastatic cancer patients: the current status, limitations, obstacles and future directions

Ann Palliat Med. 2020 Mar;9(2):121-125. doi: 10.21037/apm.2020.02.23. Epub 2020 Mar 5.

Author

Affiliation

¹ Department of Clinical Oncology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China. yaushy@ha.org.hk.

PMID: 32156134
DOI: 10.21037/apm.2020.02.23

No abstract available

Publication types

Editorial

MeSH terms

Cancer Vaccines / immunology
Clinical Trials as Topic
Drug Delivery Systems / trends
Humans
Immunologic Factors / therapeutic use*
Immunotherapy / trends*
Molecular Targeted Therapy / trends*
Neoplasm Metastasis
Neoplasms / therapy*

Substances

Cancer Vaccines
Immunologic Factors